A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction

A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction

(1) To investigate the role of azurocidin, an antimicrobial protein, in patients with ST segment elevation myocardial infarction (STEMI). (2) This single-center prospective observational study included patients with STEMI and healthy age- and sex-matched control subjects. Baseline demographic, clini...

Full description

Bibliographic Details
Main Authors: Emrah Ipek, Mustafa Yolcu, Erkan Yildirim, Konca Altinkaynak, Saime Ozbek Sebin, Kamuran Kalkan, Oktay Gulcu, Emrah Ermis, Mustafa Ozturk
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:International Journal of Molecular Sciences
Subjects:
azurocidine
inflammation
ST segment elevation myocardial infarction
Online Access:https://www.mdpi.com/1422-0067/19/12/3797

Internet

https://www.mdpi.com/1422-0067/19/12/3797

Similar Items